Introduction
The dual-speci®city protein tyrosine phosphatases (DSPs) are members of the larger family of protein tyrosine phosphatases (PTPs) and have been implicated as central regulators of mitogenic and other signaling pathways mediated by the families of MAP (mitogenactivated protein) kinases (Keyse, 1998) . The MAP kinases play a fundamental role in mediating intracellular signaling events triggered by mitogens, growth factors and stress (Ip and Davis, 1998; Robinson and Cobb, 1997) . In response to extracellular stimuli, MAP kinases are activated by their speci®c upstream dualspeci®city kinases (MAP-kinase kinases) through phosphorylation on both threonine and tyrosine residues in the TxY motif. Activated MAP kinases then phosphorylate an array of cellular substrates that ultimately lead to changes in transcription of speci®c genes. In mammals, three distinct MAP kinase families have been well characterized. The ERK MAP kinase family is activated by growth and dierentiation factors and by phorbol esters (Hill and Treisman, 1995) . The JNK family (or SAPK) and p38 MAP kinase family are activated by proin¯ammatory cytokines and cell stress (Davis, 1999) .
Although much less is known about the downregulatory mechanisms, several members of the DSPs family have been shown to dephosphorylate both Thr and Tyr of the various MAP kinases (Groom et al., 1996; Kwak and Dixon, 1995; Sun et al., 1993; Ward et al., 1994) . Studies have shown that these MAP kinase phosphatases (MKPs) harbor distinct substrate preferences for the various MAP kinase families. Most MKPs are immediate-early genes and are induced by various mitogens, growth factors and stresses. The distinct stimuli and the cell-speci®c expression suggest great diversity in function for the various MKPs. For example, MKP-1 is induced by stress, mitogens and T-cell activation and is found in the nucleus of hematopoietic cells (Ward et al., 1994) . MKP-3/VH6 is predominantly cytosolic and is induced by nerve growth factor (Mourey et al., 1996) .
Recent reports have demonstrated the involvement of single-speci®city phosphatases in MAP kinase regulation (Reviewed in Keyse, 2000) . Several of these phosphatases are constitutively-expressed and their phosphatase activity appears to be highly regulated through an unknown mechanism. In the heat shock response, evidence suggests that the robust activation of the stress-activated protein kinases is the result of transient inhibition of these phosphatases and not from the activation of the upstream MKK (Meriin et al., tyrosine phosphatase (Pyp1) that dephosphorylates and inactivates the stress MAP kinase Spc1 is inhibited for its interaction with Spc1, leading to strong inactivation of the Spc1 pathway (Nguyen and Shiozaki, 1999) . In mammalian cells, protein-damaging stresses were shown to activate JNK by inhibition of dephosphorylation. Expression of the major heat-shock protein Hsp27 was shown to inhibit the repression of JNK dephosphorylation Yaglom et al., 1999) .
In the present study, we demonstrate that the tyrosine-speci®c and constitutively-expressed phosphatase VHR (for VH1-Related) down-regulates the JNK signaling pathway at the level of JNK dephosphorylation. VHR was shown to eciently dephosphorylate JNK and to form a tight complex with activated JNK when the catalytically-inactive C124S VHR mutant was employed as an in vivo substrate trap. Using an in vitro assay, the transcription factor c-Jun speci®cally inhibited the ability of VHR to dephosphorylate JNK by sterically blocking access to the phosphorylation sites when JNK and c-Jun form a complex. The c-Jun inhibition results are discussed in terms of the resistantnature of JNK dephosphorylation in cellular extracts and in terms of a general model in which VHR may be a general MAP kinase phosphatase whose speci®city and activity are dictated by the presence of MAP kinase-associated proteins that inhibit dephosphorylation by speci®cally blocking access to the phosphorylated activation lip.
Results and Discussion
JNK2 is an in vitro substrate for VHR, but not for VH6/MKP3 and PP2C Initially, we examined the relative rates of JNK dephosphorylation by several distinct classes of protein phosphatases. Because of the ability to express and purify mg quantities of phosphorylated kinase employing a previously published method (Khokhlatchev et al., 1997) , JNK2 was used as a suitable recombinant substrate for the in vitro dephosphorylation assays. Catalytic concentrations of the tyrosine-speci®c phosphatase VHR, the dual-speci®city phosphatase VH6/ MKP3, and the serine/threonine speci®c phosphatase PP2Ca were employed, and the rate of dephosphorylation was measured using Western blot analysis. Recombinant VHR, VH6/MKP3, or PP2Ca, at a ®nal concentration of 0.1 mM, were combined with 1 mM recombinant phosphorylated JNK2. Dephosphorylation was assessed by Western blot analysis using an antibody that speci®cally recognizes the diphosphorylated active form of JNK. Phosphoester hydrolysis at either threonine, or tyrosine, or both is therefore detectable by this approach. PP2Ca and VH6/MKP3 displayed little or no activity (510% change) towards phosphorylated JNK2 under the conditions of the experiments (Figure 1a) . In dramatic contrast, VHR was able to dephosphorylate JNK with an apparent second-order rate constant of 40 000 M 71 s 71 ( Figure  1a,b) . It has been previously demonstrated that both VHR and VH6/MKP3 dephosphorylated ERK in vitro and in vivo (Mourey et al., 1996; Muda et al., 1996; Todd et al., 1999) . The in vitro rate of inactivation/ dephosphorylation was reported to be 20 000 ± 40 000 M 71 s 71 (Todd et al., 1999) , similar to the observed rate between VHR and JNK2 (Figure 1 ). VH6/MKP3 was shown to be a transcriptionally induced enzyme that is thought to down-regulate ERK through a feed-back mechanism (reviewed in Keyse (2000) ). VHR was shown to be a constitutively expressed and tyrosine speci®c phosphatase that is responsible for the rapid inactivation phase of ERK down regulation (Todd et al., 1999) . The serine/ threonine phosphatase PP2Ca is known to down regulate the JNK and p38 stress-kinase pathways (Nguyen and Shiozaki, 1999; Takekawa et al., 1998) ; however, only p38 has been implicated as a direct substrate of PP2Ca (Takekawa et al., 1998) . Our kinetic dephosphorylation experiments are consistent with these previous observations; however, the ecient JNK2 dephosphorylation by VHR was unexpected. These data suggested that JNK may be a physiological substrate of VHR.
VHR down-regulates the JNK pathway in response to stress
We examined the possibility that the stress-activated protein kinase JNK is an authentic substrate of VHR. To address the function of VHR on JNK cellular signaling, transient and stable-transfection studies were preformed. Stable-transfection of either human VHR or the catalytically inactive mutant C124S were generated in NIH3T3 mouse ®broblasts. NIH3T3 cells were an ideal cell line to examine the in vivo functions of VHR since endogenous levels of VHR are negligible compared to many common cell lines (Figure 2a and Todd et al. (1999) ). VHR protein levels in the NIH3T3 stable cell lines were similar to the endogenous levels observed in other cell lines, such as COS1 (Figure 2a and Todd et al. (1999) ). Also, we have previously shown that endogenous, constitutive levels of VHR do not change after a variety of mitogenic stimulation (Todd et al., 1999) . Therefore, the stable cell lines provide a relevant in vivo system to examine function.
The stable cell lines NIH3T3-VHR, NIH3T3-C124S and parental NIH3T3 cells were treated with various cell stresses (heat shock and anisomycin) to induce JNK MAP kinase activation, and the ability of VHR to down-regulate JNK phosphorylation was assessed. Phosphorylation of JNK was determined by Western blot analysis (Figure 2b ,c) using an antibody that speci®cally recognizes the active diphosphorylated form of the kinase (Todd et al., 1999) . In all NIH3T3 cell lines, heat-shock and anisomycin induced the activation of JNK which reached maximal activation between 30 ± 60 min (Figure 2b,c) . However, in cells expressing active VHR, the magnitude of the heat shock or anisomycin-induced activation was at least ®vefold lower than that observed in parental NIH3T3 cells. All cell lines were shown to express similar levels of JNK protein (Figure 2b,c) . Cells expressing the inactive C124S mutant exhibited no decrease in JNK phosphorylation (Figure 2b ,c). These data suggested that JNK may be an in vivo substrate of the DSP VHR.
However, to demonstrate that VHR was acting directly at the level of JNK and not on the upstream components of the signaling pathway, the eect of VHR expression on SEK activation was evaluated. SEK (MKK4) is a speci®c JNK kinase responsible for activating the kinase through dual-phosphorylation of T and Y in the TxY activation motif (Davis, 1999) . Since heat shock and anisomycin treatments do not signi®cantly induce SEK activation above basal levels (Figure 2d ,e), osmotic stress (700 mM NaCl) was necessary to robustly activate SEK and visualize any changes in SEK activation that could be generated from VHR over-expression. SEK activation was determined using Western blot analysis with an antibody that speci®cally recognizes the active phosphorylated form of the kinase (Takekawa et al., 1998) . No signi®cant dierences in SEK activation were observed between parental cells and those expressing VHR or the catalytic mutant C124S (Figure 2e ). These data suggested that VHR was not acting on or upstream of SEK, but rather, was acting at the level of JNK.
To corroborate these stable transfection studies and the in vitro kinetic analysis, transient transfections were performed in both COS1 and NIH3T3 cells. HA-tagged JNK was co-transfected with either VHR or an antisense VHR construct. Transfected cells with increasing amounts of either pcDNA3-VHR or pcDNA3-antisense-VHR were treated with anisomycin for 30 min and the levels of phosphorylated JNK were determined by Western blot analysis ( Figure 3 ). Overexpression of VHR abrogated HA-JNK activation at 30 min of anisomycin stimulation in both COS1 ( Figure 3a ) and NIH3T3 cells (Figure 3b ). In control experiments, cells transfected with anti-sense VHR or vector control exhibited robust activation. These results indicate that there is a direct correlation between the phosphorylation of JNK and the cellular levels of VHR.
Using heat shock or anisomycin to stimulate the stress response pathway, the time-course for JNK activation and dephosphorylation was examined ( Figure 4 ). Cells were transfected with either pcDNA3-VHR or pcDNA3-antisense-VHR and cotransfected with HA-tagged JNK. Cells were either treated with anisomycin ( Figure 4a ) or heat-shocked ( Figure 4b ) and the time-course of JNK dephosphorylation was assessed by Western analysis as before. In the control antisense-VHR cells, both endogenous and transfected HA-JNK1 proteins were activated maximally at 30 min. After 1 ± 2 h, all forms of JNK were signi®cantly dephosphorylated. However, in the anisomycin-treated cells co-expressing both HA-JNK1 and VHR, the amplitude of HA-JNK1 activation was greatly diminished (eightfold), and the level of activation decreased to basal levels within 1 h ( Figure 4a ). With heat-shock cells, VHR completely abolished HA-JNK activation over the entire 2 h time-course ( Figure 4b ). Figure 4a provides addition support that up-stream components of the pathway are not likely aected by VHR, since low but signi®cant JNK activation was observed upon anisomycin stimulation, but was rapidly inactivated by expressed VHR. These data indicate that VHR does not aect the normal timing of stress activation of the JNK pathway, providing support that VHR is acting A B Figure 1 Recombinant JNK2 is dephosphorylated by VHR but not VH6 or PP2Ca phosphatases. VHR, VH6, or PP2Ca (0.1 mM) were incubated with phosphorylated JNK2 (1.0 mM) at 308C for 0 ± 40 min (pH 6.8). (a) Western blot analysis of dephosphorylation using antibodies speci®c to the dually-phosphorylated form of JNK or to phospho-tyrosine. (b) Progress curve of JNK2 dephosphorylation by VHR. Level of phosphorylated JNK2 remaining at the indicated times was quanti®ed using densitometry (Molecular Analyst Software, Bio-Rad). The (dephosphorylated JNK) was calculated and data were ®tted to the integrated Michaelis-Menton equation (Denu et al., 1995) to obtain the k cat /k m value at the level of JNK. The fact that the both stable and transient transfections in NIH3T3 and COS1 cells yielded similar results for a variety of cell stresses provides ample evidence for a role of VHR in JNK down-regulation.
In vivo association of C124S VHR and diphosphorylated JNK
To demonstrate the physical association of VHR and JNK MAP kinase, substrate trapping experiments were (e) Anti-phospho-SEK1/MKK4 Western blot of NIH3T3, NIH3T3-VHR, and NIH3T3-C124S cell lines treated with NaCl. Cells were grown to 80 ± 90% con¯uence before treatment with 41 mg/ml NaCl, 10 mg/ml anisomycin, or heat shock at 458C performed using the NIH3T3-C124S stable cell line. We and others have previously utilized catalytic mutants to trap cellular substrates of PTPs and DSPs (Black and Bliska, 1997; Flint et al., 1997; Tiganis et al., 1998; Todd et al., 1999) . VHR (C124S) was immunoprecipitated from extracts of anisomycin treated cells and the co-association of active, endogenous JNK was assessed by Western analysis (Figure 5a ). Diphosphorylated JNK1 and JNK2 were found associated with C124S VHR, although much less JNK2 was observed. In control immunoprecipitates, no diphosphorylated JNK was detectable (Figure 5a ). These data provide direct evidence for the relevant association of JNK with VHR. The trapping experiment showed that phospho-JNK1 was more eciently trapped than phospho-JNK2. This is consistent with the data in Figure 2 which indicated that although both JNK1 and JNK2 are dephosphorylated in cells, a greater percentage of the total JNK1 is dephosphorylated relative to JNK2 at early times ( Figure 2b ). To further corroborate the in vivo association of VHR and JNK, the reciprocal trapping experiments were performed (Figure 5b) . In COS1 cells, the JNK pathway was activated by heat shock and the ability of C124S VHR to interact with phosphorylated HA-JNK1 was assessed by immuno-precipitating tagged JNK and detecting the presence of C124S VHR (Figure 5b ). Indeed, VHR (C124S) was found to associate with phospho-HA JNK1 when both proteins were transiently expressed. The accompanying control immunoprecipitations display no detectable VHR, when either protein is expressed alone (Figure 5b ).
c-Jun inhibits in vitro JNK dephosphorylation by VHR
Collectively, our data suggest that JNK is an authentic substrate of VHR; however, previously we observed little to no dephosphorylation of endogenous JNK by recombinant VHR when cell extracts were used as a source of activated JNK (Todd et al., 1999) . In these previous experiments, COS1 cells were treated with anisomycin and extracts were then generated from the harvested cells. To these extracts, catalytic amounts of VHR were added and the dephosphorylation of JNK was assessed. Compared to ERK, only negligible rates of JNK dephosphorylation were observed. Here, we explored the apparent discrepancy between these observations and those described in the current study. JNK is known to form tight complexes with a variety of proteins including c-Jun (May et al., 1998) , GST (Adler et al., 1999) , p21 cip/waf1 (Patel et al., 1998; Shim et al., 1996) and various transcription factors (Gupta et al., 1996; Ip and Davis, 1998) . Although, the functional signi®cance of these associations are not completely understood, we postulate that these protein interactions may inhibit the ability of VHR (and other phosphatases) to dephosphorylate JNK. Complex formation with JNK is likely to be highly regulated in the cell; however, we suggest that when cells are lysed and the compartmentalization is lost, many of these proteins are now free to associate with JNK. We tested the hypothesis that binding of JNK-associated proteins attenuates the dephosphorylation by VHR. This idea was examined under stringent in vitro conditions using recombinant, puri®ed transcription factor c-Jun, phosphorylated JNK and VHR phosphatase. VHR was combined with phosphorylated JNK and either c-Jun or an equivalent volume of buer. The dephosphorylation reactions were allowed to proceed for up to 40 min at 308C, pH 7. The samples were then subjected to Western analysis to examine the phosphorylation state of JNK (Figure 6a) , and the resulting data quanti®ed in Figure 6b . The inclusion of equal molar or greater amounts of c-Jun clearly inhibited the ability of VHR to dephosphorylate active JNK. In control experiments, c-Jun had no eect on the ability . Because c-Jun had no eect on the ability of VHR to dephosphorylate ERK, c-Jun must bind to JNK, but not VHR, to inhibit the reaction. Together, this data strongly suggest that cJun binds to JNK and prevents binding of JNK to VHR by lowering the eective concentration of substrates. This can also be thought of as lowering the anity of VHR for JNK when JNK is complexed with c-Jun. A functional JNK kinase assay also was performed in order to directly correlate kinase activity with the extent of VHR-dependent dephosphorylation. VHR (0.3 mM) was combined with 1 mM phosphorylated JNK and either 5 ± 10 mM recombinant c-Jun or an equivalent volume of buer. Aliquots were withdrawn at the indicated times and the remaining kinase activity was measured. The fraction of remaining kinase activity was determined and is plotted in Figure  6c . Again, c-Jun was able to inhibit dephosphorylation of JNK by VHR. At 10 mM c-Jun, the rate of dephosphorylation was slowed by twofold relative to the rate in the absence of c-Jun. Since c-Jun has no inhibitory eect on the ability of VHR to dephosphorylate ERK (Figure 6a ) and small arti®cial substrates (data not shown), c-Jun likely exerts its eect by directly binding to JNK and protecting the enzyme against VHR dephosphorylation.
The interaction between c-Jun and JNK has been characterized recently by May et al. (1998) . Although c-Jun is a substrate of JNK, the interactions between the two proteins was more elaborate than the simple association of enzyme and substrate. The c-Jun delta region is essential for binding JNK, but is not sucient. The c-Jun DNA-binding domain also contains distinct binding interactions with JNK. These interactions appear to be independent of the delta domain. It has been proposed that JNK can be Figure 4 Time-course of JNK activation and dephosphorylation. COS-1 cells were transiently transfected with 3 mg HA-JNK plasmid, 5 mg pcDNA3-anti-VHR or pcDNA3-VHR, and 2 mg pcDNA3. Cells were treated with 10 mg/ml anisomycin (a) or were heat shocked at 458C (b) for the indicated times. In (a) and (b) upper panels, anti-phospho-JNK Western blot; middle panels, anti-VHR Western blot; lower panels, anti-HA Western blot Down-regulation of JNK by VHR phosphatase JL Todd et al tethered to c-Jun through multiple independent interactions, that c-Jun can be phosphorylated without dissociation from the complex, and that these additional interactions may serve a regulatory cycle (May et al., 1998) . Logically, our data suggest that the physical association of c-Jun with JNK generates a steric block which prevents dephosphorylation by VHR. Though we are not implying that c-Jun binding is the basis for the incredible stability of phosphorylated JNK in cell extracts, it is highly probable that one or more of the known binding proteins are complexed with JNK and are preventing dephosphorylation. In similar cell-extract experiments (Todd et al., 1999 , and data not shown), VHR was capable of ecient ERK dephosphorylation, suggesting that the observed inhibition of JNK dephosphorylation is not due to direct inhibition of VHR.
In the current study, we demonstrate the ecient in vitro and in vivo dephosphorylation of JNK by VHR and provide a plausible mechanism for the recalcitrant nature of JNK dephosphorylation in cell extracts. Consistent with JNK as a physiological substrate, active JNK is associated with the catalytically-inactive C124S VHR mutant. In COS1 cells, it was recently shown that ERK1 and ERK2 were in vivo substrates of VHR (Todd et al., 1999) . Interestingly, when the C124S VHR immunoprecipitation blots ( Figure 5) were reprobed for the presence of ERK, only very weak association was detected from these anisomycin-treated NIH3T3 cells (data not shown). It is quite possible that activated ERK is shielded from VHR in a similar fashion to what was observed with the JNK/c-Jun complex ( Figure 6 ). We suggest that MAP kinases can be protected from VHRdependent dephosphorylation by the speci®c binding of other MAP kinase-binding proteins. Thus, we propose that VHR may be a general MAP kinase phosphatase whose activity is governed by its ability to gain access to the phosphorylation sites, which can be directly blocked by MAP kinase-associated proteins.
Recently, Alonso et al. (2001) have suggested that VHR may be involved in inhibiting the T cell antigen receptor-and the CD28-induced activation of ERK and JNK in Jurkat T cells (Alonso et al., 2001) . Overexpression of exogenous VHR in Jurkat T cells resulted in a marked decrease in ERK-and JNKdependent transcriptional activation of several gene reporter constructs. Consistent with our evidence for direct association of VHR and JNK (current study), Alonso et al. (2001) observed that overexpression of catalytic mutants of VHR behaved as`dominantnegatives', since overexpression led to increased gene expression in several of their experiments (Alonso et al., 2001) . To act as a dominant-negative, the inactive mutants would likely bind to and prevent JNK dephosphorylation by endogenous phosphatases like VHR.
Several reports have suggested that JNK activation by heat-shock and other protein-damaging agents results from the suppression of constitutive phosphatases. Sherman and colleagues Yaglom et al., 1999) have demonstrated the involvement of the major heat shock protein Hsp72 in this process. Elevated levels of Hsp72 reverse the inhibition of JNK dephosphorylation induced by protein-damaging reagents. The mechanism for this Hsp72-dependent de-repression of phosphatase activity is not known. Given our observations that JNK-binding proteins such as c-Jun can directly prevent dephosphorylation (Figure 6 ), suggests a possible mechanism which controls the rate of dephosphorylation in cells. Many of these JNK-associated proteins, like c-Jun, are known to be highly unstable proteins (Jariel-Encontre et al., 1997; Salvat et al., 1998) . As is known (Hartl and Martin, 1995) , partially denatured proteins can eciently bind to heat shock proteins such as Hsp72. It is then possible to envision that when Hsp72 levels rise, there is mass-action transfer of JNK-associated proteins from JNK to Hsp72. Transfer to Hsp72 would alleviate the phosphatase inhibitory block and allow for ecient dephosphorylation of JNK. Interestingly, c-Jun expression has been shown to play a role in the heat shock-induced apoptosis of HL-60 cells (Kondo et al., 2000a) . Also, expression of Hsp70 (Kondo et al., 2000b) and Hsp27 (Buzzard et al., 1998) have been demonstrated to be strong anti-apoptotic factors (Volloch and Sherman, 1999) , providing cell survival after such cell-stress as ceramide and heat shock. Because the JNK pathway plays a critical role in driving apoptosis (Davis, 1999) , it is an attractive idea to suggest that these anti-apoptotic heat-shockproteins may directly alleviate the inhibition of dephosphorylation by sequestering JNK-associated factors.
Materials and methods

Reagents and mammalian vectors
The human full length cDNA of VHR or the C124S mutant of VHR were cloned out of pT7-7-VHR using polymerase chain reaction and inserted into the BamHI (5' end) and EcoRI (3' end) sites of pcDNA3 vector (Invitrogen) to generate pcDNA3-VHR and pcDNA3-C124S, respectively (Todd et al., 1999) . Both constructs direct the expression of all 185 amino acids with no vector added sequences. The RSV-c-Jun plasmid was a gift from Dr David Pribnow. The full length human c-Jun open reading frame was cloned out of the cDNA using the polymerase chain reaction (5' primer CAACGTATCATATGACTGCAAAGATGGAA, 3' primer CCGCTCGAGAAATGTTTGCAACTGCTG), and inserted into the NdeI (5' end) XhoI (3' end) sites of pET-24b vector (Novagen). All constructs were veri®ed by DNA sequencing. Recombinant c-Jun was puri®ed from inclusion bodies and refolded out of 8 M urea. Urea was removed by dialysis and the c-Jun preparation was further puri®ed by G-75 size exclusion chromatography. The hemagglutinin-tagged JNK1 (HA-JNK1) expression vector was a gift from Dr Phil Stork (Vollum Institute, Oregon Health Science University). For the expression and phosphorylation of recombinant rat JNK2 (SAPK), an ampicillin resistant plasmid containing JNK2 and its upstream MAP kinase kinase (human MEK4) were cotransformed with a kanamycin resistant plasmid containing the upstream MAP kinase kinase kinase (rat MEKK1) into bacterial strain BL21DE3 (Khokhlatchev et A B Figure 5 (a) In vivo association of endogenous active JNK with catalytically-inactive C124S VHR mutant, and (b) in vivo association of phospho-HA-JNK with catalytically-inactive C124S VHR mutant using transient transfection. (a) Stable NIH3T3-C124S cells were treated with 10 mg/ml anisomycin for 30 min at 378C and lysed with 50 mM Bis-Tris, pH 6.5, 50 mM NaCl, 1% Nonidet P-40, 100 mM PMSF, 20 mg/ml aprotinin, 20 mg/ml leupeptin, 10 mM NaF, and 5 mM EDTA. Cell lysates were combined with an equal volume of ethanolamine capped A-Gel 10 (control immunoprecipitation) or a polyclonal chicken antibody speci®c to VHR (Todd et al., 1999) coupled to A-Gel 10 and incubated for 1 h at 48C. The resins were washed three times in 7 volumes of 10 mM Bis-Tris, pH 6.5, 10 mM NaCl, 0.2% Nonidet P-40 and resuspended in 26Laemmli sample buer containing SDS and resolved by SDS ± PAGE. Samples were analysed by Western blotting with antibodies that recognize active JNK (upper panel) and VHR (lower panel). (b) Cos-1 cells were transfected with 10 mg of the indicated plasmids (20 mg of total transfected DNA per lane). DNA Lysates were immunoprecipitated using a monoclonal anti-HA antibody and precipitates were subjected to SDS ± PAGE followed by Western blotting using anti-phospho JNK; upper panel, anti-JNK; middle panel and anti-VHR antibodies; lower panel al., 1997). Both plasmids were gifts from Dr Melanie Cobb. The transformed bacteria were grown on selective 2xYT media containing 50 mg/l kanamycin and 100 mg/ml ampicillin. Colonies selected from the plates were used to inoculate 1L 2xYT containing 50 mg/l kanamycin and 140 mg/l ampicillin. When bacterial growth reached an optical density of 0.4 at 600 nm, isopropyl b-D-thiogalactopyranoside (IPTG) was added at 100 mg/l and cells were incubated at 258C for 14 h. The His 6 -tagged recombinant JNK2 was puri®ed from the bacterial lysate using Ni 2+ -NTA agarose (Qiagen) as described previously (Robbins et al., 1993) . To determine the speci®c activity of the puri®ed phospho-JNK2, myelin basic protein was used as a substrate as described previously, except that the reactions were terminated by spotting onto P81 phospho-cellulose disks (Gibco BRL) and counted for [ 32 P] in the product (from [ 32 P]-ATP substrate) using a liquid scintillation counter. The speci®c activity of the active, phosphorylated JNK2 was 0.8 ± 1 mmol/min/mg protein, similar to the previously published value 1 ± 2 mmol/min/mg for fully diphosphorylated JNK2. Therefore, complete phosphorylation was assumed when initial phospho-JNK2 concentrations were determined for the dephosphorylation reactions. Rabbit and chicken anti-VHR immunoglobulins were generated as described previously (Todd et al., 1999) and stored in 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 PO 4 , and 1.4 mM KH 2 PO 4 (Phosphate buered saline, PBS).
Western blotting
Proteins were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to membranes of Immobilon-P PVDF (millipore) at 125 V for 45 ± 50 min. Membranes were rinsed with 0.15 M NaCl and 0.01 M Tris (Tris buered saline, TBS) containing 0.05% Tween 20 (TBST) then blocked with TBST containing either 5% bovine serum albumin (BSA) (Sigma) or non-fat dry milk for 1 h at 258C. The membranes were incubated with immunoglobulins, and subjected to Western analysis as described previously (Todd et al., 1999) . The following antibodies from New England Biolabs used were: anti-p44/42 MAPK rabbit polyclonal immunoglobulin (rAb), anti-phospho-p44/42 MAPK (Thr 202/Tyr 204) rAb, anti-phospho-p38 MAPK (Thr180/Tyr182) rAb, anti-phospho-SEK1/MKK4 (Thr 223) rAb, and horse anti-mouse IgG-HRP conjugate. An anti-phospho-SAPK/ JNK (Thr183/Tyr185) rAb was obtained from Promega. The anti-VHR rAb was immunopuri®ed from the serum of VHR immunized rabbits (Cocalico) (Todd et al., 1999) . The mouse monoclonal antibody (mAb) speci®c to anti-phosphotyrosine (4G10) was from Upstate Biotechnology, and the goat antirabbit IgG-horseradish peroxidase (HRP) conjugate was from Bio-Rad. HA mAb was a gift from Dr Brian Druker (Oregon Health Science University).
Cell culture, treatment, and lysis
Cells were grown at 378C in Dulbecco's Modi®ed Eagles Medium containing D-glucose 1 g/l, l-glutamine 1 g/l, pyridoxine hydrochloride 1 g/l, sodium pyruvate 110 mg/l, 10% fetal bovine serum (FBS), penicillin at 1000 units/ml, and streptomycin at 1 mg/ml (Gibco BRL) (growth medium). The stable transfected cell lines were maintained in growth medium with the addition of 350 mg/ml geneticin. For treatments, NIH3T3 cells were seeded at 1.5610 5 cells/ 35 mm plate and COS-1 cells at 2.5610 5 cells/35 mm plate. After 16 ± 24 h, cells were treated with 10 mg/ml anisomycin, 25 ng/ml platelet-derived growth factor (PDGF), 41 mg/ml NaCl, or heat shocked at 458C in a water bath. Untreated cells were sampled for the 0 time controls. After treatment, cells were rinsed once with PBS, lysed in 80 ± 100 ml of icecold, 20 mM Tris, pH 7.2, 137 mM NaCl, 10% glycerol, 1% Nonidet P-40, 2 mM ethylenediaminetetraacetic acid (EDTA), 1 mM Na 3 VO 4 , 10 mM NaF, 100 mM phenylmethylsulfonyl uoride (PMSF), 20 mg/ml leupeptin, and 20 mg/ml aprotinin. Cells were scraped into eppendorf tubes, sonicated for 10 s, and centrifuged at 16 000 g for 10 min to remove cell debris. Protein concentrations of supernatants were determined by the method of Bradford, normalized, and then subjected to Western analysis as described above.
Stable transfections in NIH3T3
NIH3T3 cells were seeded at 1.0610 6 cells/100 mm plates and grown for 16 ± 24 h. LipofectAMINE (Life Technologies, Inc.) (30 ml) and puri®ed pcDNA3-VHR or pcDNA3-C124S plasmid DNA (1 mg) were combined in 500 ml of Opti-MEM I (Life Technologies, Inc.) and incubated for 20 min at 258C. The cells were rinsed once with Opti-MEM I and the lipid/ DNA solution was added drop-wise to the cells before being covered with Opti-MEM I (5 ml). After 6 ± 8 h, growth medium was added to the transfected cells. The cells were split 1 : 15 into growth medium containing 500 mg/ml 71 Geneticin (Life Technologies, Inc.) after 48 h, and grown until individual colonies were established. Individual colonies were isolated and screened for over-expression of VHR or C124S VHR by anti-VHR Western analysis as described. Veri®ed clones were maintained in growth medium containing 350 mg/ml Geneticin.
Transient transfections
NIH3T3 cells were seeded at 1.5610 5 cells/35 mm plate or COS-1 cells were seeded at 2.5610 5 cells/35 mm plate and were grown for 24 ± 30 h. Cells were rinsed once in PBS while a transfection mixture of 100 ml FBS/penicillin/streptomycin free growth medium, 20 ml Superfect(Qiagen), 3 mg HA-JNK DNA, and 1 ± 7 mg pcDNA3-VHR or antisense pcDNA3-VHR incubated at room temperature. The total DNA concentrations were brought up 10 mg DNA using pcDNA3. Before the mixture was added drop-wise onto the cells, 600 ml of growth medium was added. After 2 ± 3 h, the transfection mixture was aspirated o, the cells were rinsed once in PBS, growth medium was added, and cells were left for 18 ± 24 h before treatment.
Dephosphorylation of Recombinant JNK2 by VHR, VH6, and PP2Ca
Recombinant VHR, VH6, or PP2Ca, at a ®nal concentration of 0.1 mM, was combined with 1 mM recombinant phosphorylated JNK2 in 50 mM Bis-Tris, 100 mM sodium acetate (TBA), pH 7.0, 1 mM dithiothreitol (DTT), 0.01% BSA, and incubated for up to 40 min at 308C (10 mM MgCl 2 was also included in all PP2Ca reactions). Aliquots were withdrawn at the indicated times and the reactions were terminated when 56 Laemmli sample buer was added. The samples were then subjected to Western analysis to examine the phosphorylation state of JNK2 using the phospho-JNK antibody. Changes in the phosphorylation of JNK2 were quanti®ed by densitometry using a Bio-Rad GS-700 Imaging Densitometer and the Molecular Analyst Software. The amount of dephosphorylated JNK2 was determined by subtracting the fraction remaining from 1 and multiplying by the initial concentration of phosphorylated JNK2. The data were then ®tted to the integrated Michaelis-Menten equation (Denu et al., 1995) .
Dephosphorylation of recombinant JNK2 by VHR in the presence of c-Jun
Recombinant VHR at a ®nal concentration of 0.1 mM, was combined with 1 mM recombinant phosphorylated JNK2 and 1 mM recombinant c-Jun, or an equivalent volume of TBA, pH 7.0, 1 mM DTT, 0.01% BSA, and incubated for up to 40 min at 308C. Aliquots were withdrawn at the indicated times and the reactions were terminated by adding 56 Laemmli sample buer. The samples were then subjected to Western analysis to examine the phosphorylation state of JNK2 using the phospho-JNK antibody. Alternatively, recombinant VHR at a ®nal concentration of 0.3 mM was combined with 1 mM recombinant phosphorylated JNK2 and 5 ± 10 mM recombinant c-Jun, or an equivalent volume of TBA, pH 6.5, 1 mM DTT, 0.01% BSA, and incubated for up to 10 min at 308C. Aliquots were withdrawn at the indicated times, mixed with 20 mM HEPES, pH 8.0, 10 mM MgCl 2 , 1 mM DTT, 1 mM Na 3 VO 4 , 10.7 mM recombinant c-Jun, 0.27 mM ATP, and 600 c.p.m./ pmol [ 32 P]-ATP (giving a ®nal JNK concentration of 20 nM), and incubated for 15 min at 308C. The reaction was stopped by spotting onto P81 phospho-cellulose disks (Gibco BRL). Disks were washed three times for 10 min in 150 mM phosphoric acid, and the incorporation of [ 32 P] into c-Jun was measured by liquid scintillation. The per cent remaining kinase activity of JNK2 was calculated by dividing the activity at each time point by the zero minute time point. Error bars indicate the standard error between two separate experiments.
Co-Immunoprecipitation of JNK with C124S VHR
NIH3T3-C124S cells were treated with 10 mg/ml anisomycin for 30 min at 378C and lysed with 50 mM Bis-Tris, pH 6.5, 50 mM NaCl, 1% Nonidet P-40, 100 mM PMSF, 20 mg/ml aprotinin, 20 mg/ml leupeptin, 10 mM NaF, and 5 mM EDTA. Cell lysates were combined with an equal volume of ethanolamine capped A-Gel 10 (control immunoprecipitation) or a polyclonal chicken antibody speci®c to VHR coupled to A-Gel 10 and incubated for 1 h at 48C. The resin was washed three times in seven volumes of 10 mM BisTris, pH 6.5, 10 mM NaCl, 0.2% Nonidet P-40 and resuspended in 26 Laemmli sample buer containing SDS. All samples were then subjected to Western analysis as described above. For the reciprocal immunoprecipitation, Cos-1 cells were transfected with superfect using 20 mg of total transfected DNA per 100-mm plate. Twenty-four hours post transfection cells were heat shocked at 458C for 45 min to induce JNK kinase activation and washed in ice-cold phosphate buered saline. Cells were lysed in 50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM EDTA, 0.5% Nonidet P-40, 1 mM phenylmethylsulfonyl¯uoride. After centrifugation (12 000 g, 10 min, 48C), soluble supernatants were collected and used for immunoprecipitations. Extracts (2 mg) were incubated with 2 mg of anti-HA antibody for 2 h with rotation at 48C. Twenty microlitres of protein G-sepharose (previously washed twice in lysis buer) were added and the incubation was continued for 2 h. Precipitates were washed twice in lysis buer (12 000 g, 1 min, 48C), and re-suspended in SDS-polyacrylamide gel electrophoresis loading buer for Western blot analysis. Samples were taken at the indicated times and were subjected to Western analysis using the phospho-JNK antibody. Recombinant phosphorylated ERK (1 mM) was utilized in a control experiment to demonstrate the lack of c-Jun-dependent inhibition of VHR (lower panel of a). (b) Quanti®cation of dephosphorylation data from Figure 6a , showing a sixfold slower k cat /K m rate constant in the presence (circles) versus the absence (squares) of c-Jun. The data were ®tted to the integrated Michaelis-Menten equation. (c) Alternatively, VHR (0.3 mM) was combined with 1 mM phosphorylated JNK and 5 ± 10 mM recombinant c-Jun, or an equivalent volume of buer and incubated for up to 10 min at 308C. Aliquots were withdrawn at the indicated times and JNK kinase assays were performed as described in Experimental procedures. Per cent remaining kinase activity of JNK was calculated. Error bars indicate the standard error between two separate experiments. Symbols: Filled circles, 0 mM VHR, 0 mM c-Jun and 1 mM JNK2; Filled squares, 0.3 mM VHR, 10 mM c-Jun and 1 mM JNK2; Open squares, 0.3 mM VHR, 5 mM c-Jun and 1 mM JNK2; and ®lled diamonds, 0.3 mM VHR, 0 mM c-Jun and 1 mM JNK2
